Literature DB >> 20230140

Predicting conversion to dementia of the Alzheimer's type in a healthy control sample: the power of errors in Stroop color naming.

David A Balota1, Chi-Shing Tse, Keith A Hutchison, Daniel H Spieler, Janet M Duchek, John C Morris.   

Abstract

In the present study, we investigated which cognitive functions in older adults at Time A are predictive of conversion to dementia of the Alzheimer's type (DAT) at Time B. Forty-seven healthy individuals were initially tested in 1992-1994 on a trial-by-trial computerized Stroop task along with a battery of psychometric measures that tap general knowledge, declarative memory, visual-spatial processing, and processing speed. Twelve of these individuals subsequently developed DAT. The errors on the color incongruent trials (along with the difference between congruent and incongruent trials) and changes in the reaction time distributions were the strongest predictors of conversion to DAT, consistent with recent arguments regarding the sensitivity of these measures. Notably in the psychometric measures, there was little evidence of a difference in declarative memory between converters and nonconverters, but there was some evidence of changes in visual-spatial processing. Discussion focuses on the accumulating evidence suggesting a role of attentional control mechanisms as an early marker for the transition from healthy cognitive aging to DAT.

Entities:  

Mesh:

Year:  2010        PMID: 20230140      PMCID: PMC2886285          DOI: 10.1037/a0017474

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  43 in total

1.  Attentional control in Alzheimer's disease.

Authors:  A D Baddeley; H A Baddeley; R S Bucks; G K Wilcock
Journal:  Brain       Date:  2001-08       Impact factor: 13.501

2.  Working-memory capacity and the control of attention: the contributions of goal neglect, response competition, and task set to Stroop interference.

Authors:  Michael J Kane; Randall W Engle
Journal:  J Exp Psychol Gen       Date:  2003-03

3.  Working memory and apolipoprotein E: what's the connection?

Authors:  V M Rosen; J L Bergeson; K Putnam; A Harwell; T Sunderland
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

4.  Attention and successful episodic encoding: an event-related potential study.

Authors:  J A Mangels; T W Picton; F I Craik
Journal:  Brain Res Cogn Brain Res       Date:  2001-03

5.  Mild cognitive impairment represents early-stage Alzheimer disease.

Authors:  J C Morris; M Storandt; J P Miller; D W McKeel; J L Price; E H Rubin; L Berg
Journal:  Arch Neurol       Date:  2001-03

6.  Preclinical prediction of AD using neuropsychological tests.

Authors:  M S Albert; M B Moss; R Tanzi; K Jones
Journal:  J Int Neuropsychol Soc       Date:  2001-07       Impact factor: 2.892

7.  Rates of progression in mild cognitive impairment and early Alzheimer's disease.

Authors:  Martha Storandt; Elizabeth A Grant; J Philip Miller; John C Morris
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

8.  Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R C Petersen; J C Stevens; M Ganguli; E G Tangalos; J L Cummings; S T DeKosky
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

9.  Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study.

Authors:  Eric M Fine; Dean C Delis; Spencer R Wetter; Mark W Jacobson; Amy J Jak; Carrie R McDonald; Jodessa C Braga; Leon J Thal; David P Salmon; Mark W Bondi
Journal:  Am J Geriatr Psychiatry       Date:  2008-05       Impact factor: 4.105

10.  Task switching capacities in persons with Alzheimer's disease and mild cognitive impairment.

Authors:  Sylvie Belleville; Louis Bherer; Emilie Lepage; Howard Chertkow; Serge Gauthier
Journal:  Neuropsychologia       Date:  2008-02-17       Impact factor: 3.139

View more
  43 in total

1.  Mindfulness, Education, and Exercise for age-related cognitive decline: Study protocol, pilot study results, and description of the baseline sample.

Authors:  Julie Loebach Wetherell; Hayley S Ripperger; Michelle Voegtle; Beau M Ances; David Balota; Emily S Bower; Colin Depp; Lisa Eyler; Erin R Foster; Denise Head; Tamara Hershey; Steven Hickman; Noralinda Kamantigue; Samuel Klein; J Philip Miller; Michael D Yingling; Jeanne Nichols; Ginger E Nicol; Bruce W Patterson; Thomas L Rodebaugh; Joshua S Shimony; Abraham Snyder; Mary Stephens; Susan Tate; Mary L Uhrich; David Wing; Gregory F Wu; Eric J Lenze
Journal:  Clin Trials       Date:  2020-06-27       Impact factor: 2.486

2.  Effects of healthy aging and early stage dementia of the Alzheimer's type on components of response time distributions in three attention tasks.

Authors:  Chi-Shing Tse; David A Balota; Melvin J Yap; Janet M Duchek; David P McCabe
Journal:  Neuropsychology       Date:  2010-05       Impact factor: 3.295

3.  Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.

Authors:  Andrew J Aschenbrenner; David A Balota; Anne M Fagan; Janet M Duchek; Tammie L S Benzinger; John C Morris
Journal:  J Int Neuropsychol Soc       Date:  2015-09       Impact factor: 2.892

4.  Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology.

Authors:  Jason Hassenstab; Sarah E Monsell; Charles Mock; Catherine M Roe; Nigel J Cairns; John C Morris; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

5.  A multistate model of cognitive dynamics in relation to resistance training: the contribution of baseline function.

Authors:  Nader Fallah; Chun L Hsu; Niousha Bolandzadeh; Jennifer Davis; B Lynn Beattie; Peter Graf; Teresa Liu-Ambrose
Journal:  Ann Epidemiol       Date:  2013-07-03       Impact factor: 3.797

6.  Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology.

Authors:  Sarah E Monsell; Charles Mock; Jason Hassenstab; Catherine M Roe; Nigel J Cairns; John C Morris; Walter Kukull
Journal:  Neurology       Date:  2014-06-20       Impact factor: 9.910

7.  Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults.

Authors:  Andrew J Aschenbrenner; David A Balota; Chi-Shing Tse; Anne M Fagan; David M Holtzman; Tammie L S Benzinger; John C Morris
Journal:  Neuropsychology       Date:  2014-09-15       Impact factor: 3.295

8.  The semantic Stroop effect: An ex-Gaussian analysis.

Authors:  Darcy White; Evan F Risko; Derek Besner
Journal:  Psychon Bull Rev       Date:  2016-10

9.  Relationship between Stroop performance and resting state functional connectivity in cognitively normal older adults.

Authors:  Janet M Duchek; David A Balota; Jewell B Thomas; Abraham Z Snyder; Patrick Rich; Tammie L Benzinger; Anne M Fagan; David M Holtzman; John C Morris; Beau M Ances
Journal:  Neuropsychology       Date:  2013-09       Impact factor: 3.295

10.  Dissociative global and local task-switching costs across younger adults, middle-aged adults, older adults, and very mild Alzheimer's disease individuals.

Authors:  Mark J Huff; David A Balota; Meredith Minear; Andrew J Aschenbrenner; Janet M Duchek
Journal:  Psychol Aging       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.